written on 12.11.2021

InFigures Asia-Pacific 2021


PharmaBoardroom’s latest report, InFigures: Asia Pacific 2021 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs.

Covering everything from population health to market growth, company rankings, innovation footprints, IPOs, and drug approvals, as well as market-specific executive insight from the PharmaBoardroom archives, this exclusive new report is an excellent jumping-off point for those looking to learn more about the world’s most dynamic region.

Featured markets include Asia-Pacific’s largest of PR China, Japan, South Korea, and Australia, as well as smaller but incredibly important innovation, financial, and logistical hubs such as Taiwan, Singapore, and Hong Kong.

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here